Sign in
CompletedNo phase

The Application of Zishen Yutai Pill in Aged Women Undergoing IVF-ET

Key facts

Who runs it
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Where
China12 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,467 people enrolled
Started
4 Mar 2019
Ended
14 Sept 2024
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Zishen Yutai Pill
  • Placebo
Record updated
25 March 2025

Who can take part

Age
35 years to 42 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • infertile women aged ≥35 and ≤42 years
  • intend to undergo IVF/ICSI-ET (GnRH-a long protocol or GnRH-ant protocol)
  • BMI<28kg/m2
  • bilateral ovaries exist
  • patients who voluntarily signed the informed consent and agreed to be followed up as required by the study protocol

Who cannot take part

  • repeated implantation failure (previous three times or more IVF/ICSI-ET failure)
  • endometrial diseases that have not been cured
  • known diseases that are not suitable for undergoing assisted reproductive technology or at the present not suitable for pregnancy
  • adenomyosis, uterine line constricted by uterine fibroid
  • untreated bilateral hydrosalpinx
  • patients who have taken traditional Chinese medicine or Chinese patent medicine for infertility treatment in the last month(30 days); Exit Criteria:
  • subjects who have adverse events cannot be tolerated
  • severe breach of the protocol
  • for subjects who exit due to personal or unpredictable reasons, please describe specific details
  • subjects considered inappropriate to continue to participate in the study for other medical reasons

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To explore the application of Zishen Yutai Pill in controlled ovarian stimulation and effect on pregnancy outcome in aged women undergoing in vitro fertilization-embryo transfer.

The 2 groups in the trial

  • Zishen Yutai pill groupTreatment being tested

    Patients who undergo the long-term protocol will start taking Zishen Yutai Pill on the day of pituitary suppression, 5g three times a day (Stopping on the first 1-4 days of menstruation), and patients who undergo the antagonist protocol will start taking Zishen Yutai Pill on the 19th to 23rd day of the previous menstruation cycle, 5g three times a day (Stopping on the first 1-4 days of menstruation). The drug will be taken till 2 weeks after transplantation. If the test result is confirmed as biochemical pregnancy (HCG\>50 IU/L), patients continue to take pills till 3 weeks after the clinical pregnancy determined by the ultrasound. If it is determined that the pregnancy test is negative, stop the drug.

    Treatment: Zishen Yutai Pill

  • Placebo groupPlacebo, for comparison

    Patients who undergo the long-term protocol will start taking Placebo on the day of pituitary suppression, 5g three times a day (Stopping on the first 1-4 days of menstruation), and patients who undergo the antagonist protocol will start taking Placebo on the 19th to 23rd day of the previous menstruation cycle, 5g three times a day (Stopping on the first 1-4 days of menstruation). The drug will be taken till 2 weeks after transplantation. If the test result is confirmed as biochemical pregnancy (HCG\>50 IU/L), patients continue to take pills till 3 weeks after the clinical pregnancy determined by the ultrasound. If it is determined that the pregnancy test is negative, stop the drug.

    Treatment: Placebo

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Application of Zishen Yutai Pill in Aged Women Undergoing in Vitro Fertilization-embryo Transfer: a Multi-center Double-blind Randomized Controlled Trial
Record updated
25 March 2025